Back to Journals » Clinical Interventions in Aging » Volume 12

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia

Total article views   HTML views PDF downloads Totals
29,924 Dovepress* 20,193+ 3,357 23,550
PubMed Central* 9,731 2,009 11,740
Totals 29,924 5,366 35,290
*Since 18 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
32 0 0 0 14 18

View citations on PubMed Central and Google Scholar